MEHMET OKCU to Remission Induction
This is a "connection" page, showing publications MEHMET OKCU has written about Remission Induction.
Connection Strength
0.069
-
Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapy. Leuk Res. 2003 Aug; 27(8):743-50.
Score: 0.051
-
Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2008 Sep; 51(3):387-92.
Score: 0.018